Graziani G - Search Results

1

Correction: VEGF-A/VEGFR-1 signalling and chemotherapy-induced neuropathic pain: therapeutic potential of a novel anti-VEGFR-1 monoclonal antibody.

Micheli L, Parisio C, Lucarini E, Vona A, Toti A, Pacini A, Mello T, Boccella S, Ricciardi F, Maione S, Graziani G, Lacal PM, Failli P, Ghelardini C, Di Cesare Mannelli L. Micheli L, et al. Among authors: graziani g. J Exp Clin Cancer Res. 2024 Apr 23;43(1):120. doi: 10.1186/s13046-024-03037-4. J Exp Clin Cancer Res. 2024. PMID: 38650002 Free PMC article. No abstract available.

2

Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines.

Tentori L, Graziani G, Gilberti S, Lacal PM, Bonmassar E, D'Atri S. Tentori L, et al. Among authors: graziani g. Leukemia. 1995 Nov;9(11):1888-95. Leukemia. 1995. PMID: 7475280

3

In vitro inactivation of human O6-alkylguanine DNA alkyltransferase by antitumor triazene compounds.

Lacal PM, D'Atri S, Orlando L, Bonmassar E, Graziani G. Lacal PM, et al. Among authors: graziani g. J Pharmacol Exp Ther. 1996 Oct;279(1):416-22. J Pharmacol Exp Ther. 1996. PMID: 8859021

4

Inhibition of O6-alkylguanine DNA-alkyltransferase or poly(ADP-ribose) polymerase increases susceptibility of leukemic cells to apoptosis induced by temozolomide.

Tentori L, Orlando L, Lacal PM, Benincasa E, Faraoni I, Bonmassar E, D'Atri S, Graziani G. Tentori L, et al. Among authors: graziani g. Mol Pharmacol. 1997 Aug;52(2):249-58. doi: 10.1124/mol.52.2.249. Mol Pharmacol. 1997. PMID: 9271347

5

Role of wild-type p53 on the antineoplastic activity of temozolomide alone or combined with inhibitors of poly(ADP-ribose) polymerase.

Tentori L, Lacal PM, Benincasa E, Franco D, Faraoni I, Bonmassar E, Graziani G. Tentori L, et al. Among authors: graziani g. J Pharmacol Exp Ther. 1998 May;285(2):884-93. J Pharmacol Exp Ther. 1998. PMID: 9580640

6

hMSH3 overexpression and cellular response to cytotoxic anticancer agents.

Pepponi R, Graziani G, Falcinelli S, Vernole P, Levati L, Lacal PM, Pagani E, Bonmassar E, Jiricny J, D'Atri S. Pepponi R, et al. Among authors: graziani g. Carcinogenesis. 2001 Aug;22(8):1131-7. doi: 10.1093/carcin/22.8.1131. Carcinogenesis. 2001. PMID: 11470740 Free article.

7

Generation of an immortalized human endothelial cell line as a model of neovascular proliferating endothelial cells to assess chemosensitivity to anticancer drugs.

Tentori L, Vergati M, Muzi A, Levati L, Ruffini F, Forini O, Vernole P, Lacal PM, Graziani G. Tentori L, et al. Among authors: graziani g. Int J Oncol. 2005 Aug;27(2):525-35. Int J Oncol. 2005. PMID: 16010436

8

Poly(ADP-ribose) glycohydrolase inhibitor as chemosensitiser of malignant melanoma for temozolomide.

Tentori L, Leonetti C, Scarsella M, Muzi A, Vergati M, Forini O, Lacal PM, Ruffini F, Gold B, Li W, Zhang J, Graziani G. Tentori L, et al. Among authors: graziani g. Eur J Cancer. 2005 Dec;41(18):2948-57. doi: 10.1016/j.ejca.2005.08.027. Epub 2005 Nov 8. Eur J Cancer. 2005. PMID: 16288862

9

Poly(ADP-ribose) polymerase (PARP) inhibition or PARP-1 gene deletion reduces angiogenesis.

Tentori L, Lacal PM, Muzi A, Dorio AS, Leonetti C, Scarsella M, Ruffini F, Xu W, Min W, Stoppacciaro A, Colarossi C, Wang ZQ, Zhang J, Graziani G. Tentori L, et al. Among authors: graziani g. Eur J Cancer. 2007 Sep;43(14):2124-33. doi: 10.1016/j.ejca.2007.07.010. Epub 2007 Aug 21. Eur J Cancer. 2007. PMID: 17714938

10

The integrin antagonist cilengitide increases the antitumor activity of temozolomide against malignant melanoma.

Tentori L, Dorio AS, Muzi A, Lacal PM, Ruffini F, Navarra P, Graziani G. Tentori L, et al. Among authors: graziani g. Oncol Rep. 2008 Apr;19(4):1039-43. Oncol Rep. 2008. PMID: 18357394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

795 results

Search Page